What was the market valuation of the US oral thrush market in 2024?

The market valuation of the US oral thrush market was $157.5 Million in 2024. Read More

What is the projected market valuation for the US oral thrush market by 2035?

The projected market valuation for the US oral thrush market is $275.5 Million by 2035. Read More

What is the expected CAGR for the US oral thrush market during the forecast period 2025 - 2035?

The expected CAGR for the US oral thrush market during the forecast period 2025 - 2035 is 5.21%. Read More

Which treatment type generated the highest revenue in the US oral thrush market?

Antifungal medications generated the highest revenue, with a valuation range of $60.0 - $100.0 Million. Read More

What segment of the US oral thrush market is projected to have the highest growth?

The segment of probiotic supplements is projected to have notable growth, with a valuation range of $27.5 - $55.5 Million. Read More

Which patient population segment holds the largest market share in the US oral thrush market?

Individuals with compromised immune systems hold the largest market share, with a valuation range of $50.0 - $90.0 Million. Read More

What is the revenue range for oral administration in the US oral thrush market?

The revenue range for oral administration is projected to be $70.0 - $120.0 Million. Read More

Which end user segment is expected to dominate the US oral thrush market?

Homecare settings are expected to dominate, with a revenue range of $67.5 - $120.5 Million. Read More

Who are the key players in the US oral thrush market?

Key players in the US oral thrush market include Pfizer Inc, GSK plc, and Merck & Co., Inc. Read More

What is the revenue range for topical medications in the US oral thrush market?

The revenue range for topical medications is projected to be $40.0 - $70.0 Million. Read More

US Oral Thrush Market

ID: MRFR/Pharma/12335-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

US Oral Thrush Market Research Report: By Type (Pseudomembranous, Erythematous, Hyperplastic, others) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Chemicals and Materials, BY Treatment Type (USD Million)
4.1.1 Antifungal Medications
4.1.2 Topical Medications
4.1.3 Oral Rinses
4.1.4 Probiotic Supplements
4.2 Chemicals and Materials, BY Route of Administration (USD Million)
4.2.1 Oral
4.2.2 Topical
4.2.3 Intravenous
4.3 Chemicals and Materials, BY Patient Population (USD Million)
4.3.1 Infants
4.3.2 Elderly
4.3.3 Individuals with Compromised Immune Systems
4.3.4 Healthy Individuals
4.4 Chemicals and Materials, BY End User (USD Million)
4.4.1 Hospitals
4.4.2 Clinics
4.4.3 Homecare Settings
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Chemicals and Materials
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 Pfizer Inc (US)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 GSK plc (GB)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Bristol-Myers Squibb Company (US)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Merck & Co., Inc. (US)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 Novartis AG (CH)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 AbbVie Inc (US)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Astellas Pharma Inc (JP)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Teva Pharmaceutical Industries Ltd (IL)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 US MARKET ANALYSIS BY TREATMENT TYPE
6.3 US MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
6.4 US MARKET ANALYSIS BY PATIENT POPULATION
6.5 US MARKET ANALYSIS BY END USER
6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
6.7 RESEARCH PROCESS OF MRFR
6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
6.12 CHEMICALS AND MATERIALS, BY TREATMENT TYPE, 2024 (% SHARE)
6.13 CHEMICALS AND MATERIALS, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
6.14 CHEMICALS AND MATERIALS, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
6.15 CHEMICALS AND MATERIALS, BY ROUTE OF ADMINISTRATION, 2024 TO 2035 (USD Million)
6.16 CHEMICALS AND MATERIALS, BY PATIENT POPULATION, 2024 (% SHARE)
6.17 CHEMICALS AND MATERIALS, BY PATIENT POPULATION, 2024 TO 2035 (USD Million)
6.18 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
6.19 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 US MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY TREATMENT TYPE, 2025-2035 (USD Million)
7.2.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Million)
7.2.3 BY PATIENT POPULATION, 2025-2035 (USD Million)
7.2.4 BY END USER, 2025-2035 (USD Million)
7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Chemicals and Materials Market Segmentation

Chemicals and Materials By Treatment Type (USD Million, 2025-2035)

Antifungal Medications
Topical Medications
Oral Rinses
Probiotic Supplements

Chemicals and Materials By Route of Administration (USD Million, 2025-2035)

Oral
Topical
Intravenous

Chemicals and Materials By Patient Population (USD Million, 2025-2035)

Infants
Elderly
Individuals with Compromised Immune Systems
Healthy Individuals

Chemicals and Materials By End User (USD Million, 2025-2035)

Hospitals
Clinics
Homecare Settings

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓